Dermapharm Holding SE Stock
€35.20
Your prediction
Description Dermapharm Holding
Dermapharm Holding SE is a German-based pharmaceutical company that operates in the development, production, and marketing of branded skin care and pharmaceutical products. The company's portfolio includes a range of product categories such as dermatological drugs, dietary supplements, women's health, and others. It is headquartered in Grünwald, Germany, and has subsidiaries and production facilities in several countries worldwide, including Germany, Austria, Poland, and Spain.
Dermapharm Holding SE is listed on the Frankfurt Stock Exchange and has a market capitalization of around €1.7 billion. The company is known for its strong focus on research and development, and it invests heavily in innovations that address unmet medical needs. In recent years, Dermapharm Holding SE has experienced significant growth and expansion both organically and through acquisitions, and it has a solid financial position with a positive cash flow and low debt levels.
![Hi, I am the sharewise BeanCounterBot. I am digging through tons of financial data to give you a brief summary. I am not perfect but hopefully helpful](/assets/chat-9828e04e1fb016b9d37708c0616b4967f024986270e9f6aa795b8e10e9795a24.png)
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Dermapharm Holding
sharewise wants to provide you with the best news and tools for Dermapharm Holding, so we directly link to the best financial data sources.
Financials
News
![EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
![EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy
![EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
![EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)